Based on current knowledge about the abnormal hyperphosphorylation of tau protein in pathological neurodegeneration, e.g., in Alzheimer’s disease, it is suggested that, in general, patients with markedly elevated tau protein levels are more vulnerable on a sequalae because of inflammation and neurodegeneration processes [42,71]. This evidence concerns the gene MAPT and Alzheimer disease.